Skip to main content

Sumitovant Biopharma Ltd.

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Sumitovant Biopharma Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 10, 2023 (view filing)9:17 AM ETMar 10Same daySumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+51.6M$27.00+$1.39BNew position45.8M after
Sep 30, 2021 (view filing)5:00 PM ETSep 282 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+20.7K$22.85+$472.4K0.0%50.0M after
Sep 28, 2021 (view filing)5:00 PM ETSep 24-274 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+84.0K$23.87+$2.00M+0.2%50.0M after3 lots
Sep 24, 2021 (view filing)5:00 PM ETSep 22-232 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+138.8K$22.39+$3.11M+0.3%49.9M after3 lots
Sep 22, 2021 (view filing)5:00 PM ETSep 20-212 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+81.3K$22.30+$1.81M+0.2%49.8M after2 lots
Sep 20, 2021 (view filing)5:00 PM ETSep 16-174 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+87.9K$22.20+$1.95M+0.2%49.7M after2 lots
Sep 16, 2021 (view filing)5:00 PM ETSep 14-152 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+161.2K$22.03+$3.55M+0.3%49.6M after3 lots
Sep 14, 2021 (view filing)5:00 PM ETSep 10-134 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+113.2K$23.84+$2.70M+0.2%49.5M after3 lots
Sep 10, 2021 (view filing)5:00 PM ETSep 8-92 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+58.9K$25.60+$1.51M+0.1%49.4M after2 lots
Sep 8, 2021 (view filing)5:00 PM ETSep 3-75 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+64.4K$26.49+$1.71M+0.1%49.3M after4 lots
Sep 3, 2021 (view filing)5:00 PM ETSep 1-22 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+103.1K$25.60+$2.64M+0.2%49.2M after4 lots
Sep 1, 2021 (view filing)5:00 PM ETAug 30-312 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+109.0K$24.05+$2.62M+0.2%49.1M after2 lots
Aug 30, 2021 (view filing)5:00 PM ETAug 26-274 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+77.0K$22.91+$1.77M+0.2%49.0M after2 lots
Aug 26, 2021 (view filing)5:00 PM ETAug 24-252 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+63.0K$22.40+$1.41M+0.1%48.9M after2 lots
Aug 24, 2021 (view filing)5:00 PM ETAug 20-234 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+101.9K$21.65+$2.21M+0.2%48.9M after3 lots
Aug 20, 2021 (view filing)5:00 PM ETAug 18-192 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+63.9K$21.49+$1.37M+0.1%48.8M after2 lots
Aug 18, 2021 (view filing)5:05 PM ETAug 16-172 daysSumitomo Pharma Co., Ltd. and 2 others10% OwnerPPurchase+71.7K$21.21+$1.52M+0.1%48.7M after3 lots